ERBB3 is known to primarily function as an oncogene for the activation of PI3K/AKT and ERK signaling to promote tumor cell proliferation or differentiation; hence, we believe that the inactivation of these pathways might limit cell proliferation, leading to dysplasia of multiple organs. The gene discussed is AKT1; the disease is neoplasm.